Data is not available at this time.
Value HR Co., Ltd. operates in Japan's healthcare information services sector, specializing in corporate health and welfare solutions. The company's core revenue model revolves around its Value Cafeteria welfare support system, which integrates medical checkup agency services, industrial health consulting, and administrative outsourcing for enterprises. It also offers digital health management tools, including stress check systems and electronic application platforms for health insurance societies. Positioned as a comprehensive provider of employer-focused healthcare services, Value HR serves a niche market by combining regulatory compliance support with data-driven health management. The company differentiates itself through integrated solutions that streamline corporate health administration while addressing Japan's aging workforce and rising healthcare costs. Its diversified service portfolio allows it to capture recurring revenue from long-term contracts with enterprises and health insurance societies.
For the fiscal year ending December 2024, Value HR reported revenue of ¥8.38 billion and net income of ¥791 million, translating to a diluted EPS of ¥29.53. The company demonstrates solid cash generation with operating cash flow of ¥2.02 billion, supported by a capital-light model as evidenced by modest capital expenditures of -¥151 million. This reflects efficient conversion of services into cash flow.
The company maintains stable earnings power with a net margin of 9.4%, supported by recurring revenue streams from its welfare support systems and consulting services. Capital efficiency appears balanced, with ¥5.49 billion in cash reserves against ¥5.61 billion in total debt, indicating manageable leverage for its asset-light operations in the healthcare services sector.
Value HR's balance sheet shows liquidity with ¥5.49 billion in cash and equivalents, providing coverage for its ¥5.61 billion total debt. The near parity between cash and debt suggests prudent financial management, though the modest net cash position warrants monitoring of interest rate exposure given Japan's monetary policy environment. The capital structure appears appropriate for its service-based business model.
The company has established a dividend policy with ¥25 per share distributed, reflecting a payout ratio of approximately 85% of diluted EPS. This high payout ratio may indicate maturity in its core markets, with growth likely coming from incremental service expansions rather than aggressive reinvestment. Japan's corporate health sector tailwinds could support low-to-mid single-digit organic growth.
With a market capitalization of ¥41.8 billion, the company trades at approximately 5x revenue and 53x net income. The elevated earnings multiple suggests market expectations for steady cash flows from its entrenched corporate health services, though growth prospects appear priced in. The low beta of 0.206 indicates defensive characteristics typical of healthcare services stocks.
Value HR benefits from regulatory tailwinds as Japanese employers face increasing health compliance requirements. Its integrated service platform creates switching costs for corporate clients. Near-term challenges include managing debt service costs in a rising rate environment. The outlook remains stable given recurring revenue streams, with potential upside from digital health adoption and enterprise wellness program expansion.
Company filings, Tokyo Stock Exchange disclosures
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |